Sanofi
Sanofi is an R&D-driven, AI-powered biopharmaceutical company developing medicines and vaccines in immunology, neurology, oncology, rare diseases and vaccines, with 80 compounds in clinical development.
Sanofi is an R&D-driven, AI-powered biopharmaceutical company that develops medicines and vaccines across five core therapeutic areas: immunology, neurology, oncology, rare diseases, and vaccines. Its clinical pipeline comprises 80 compounds in development, 28 of which are in Phase 3 trials. The company applies artificial intelligence and machine learning across its R&D value chain, from drug discovery through clinical development.
The company employs more than 100,000 people and operates in over 70 countries. Its stated purpose is to "chase the miracles of science to improve people's lives", and it describes a culture built on collaboration, curiosity and scientific progress, with global teams connected across time zones.
Sanofi states a commitment to acting responsibly towards patients, the planet and its employees while pursuing growth. Further information on the organisation and its work is available at https://sanofi.com/.